Creative Medical Technology Holdings (CELZ) Operating Income (2010 - 2026)

Creative Medical Technology Holdings (CELZ) has reported Operating Income for 17 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Income fell 23.64% year-over-year to -$1.6 million in Q2 2026; TTM through Jun 2026 was -$6.2 million, a 5.42% decrease from a year earlier, with the FY2025 full-year figure at -$6.1 million, down 6.95% from the prior year.
• Operating Income was -$1.6 million for Q2 2026 at Creative Medical Technology Holdings, down from -$1.5 million in the prior quarter.
• Over five years, Operating Income peaked at -$1.0 million in Q3 2022 and troughed at -$6.3 million in Q4 2022.
• A 5-year average of -$1.7 million and a median of -$1.5 million in 2023 frame the typical range for Operating Income.
• Across the five-year window, Operating Income sank 326.28% in 2022 and surged 71.78% in 2023, its largest moves.
• Over 5 years, Operating Income stood at -$6.3 million in 2022, then surged by 71.78% to -$1.8 million in 2023, then retreated by 6.43% to -$1.9 million in 2024, then dropped by 3.18% to -$1.9 million in 2025, then advanced by 19.72% to -$1.6 million in 2026.
• The last three Operating Income figures came in at -$1.6 million (Q2 2026), -$1.5 million (Q1 2026), and -$1.9 million (Q4 2025), per Business Quant data.